tiprankstipranks
Raymond James says AxoGen selloff ‘overdone,’ raises price target to $18
PremiumThe FlyRaymond James says AxoGen selloff ‘overdone,’ raises price target to $18
3M ago
AxoGen trading resumes
Premium
The Fly
AxoGen trading resumes
3M ago
AxoGen trading halted, volatility trading pause
Premium
The Fly
AxoGen trading halted, volatility trading pause
3M ago
AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft®
PremiumCompany AnnouncementsAxoGen Seeks Accelerated FDA Review for Avance Nerve Graft®
5M ago
AxoGen completes submission of BLA to U.S. FDA for Avance Nerve Graft
Premium
The Fly
AxoGen completes submission of BLA to U.S. FDA for Avance Nerve Graft
5M ago
AxoGen reports inducement grant under Nasdaq listing rule
Premium
The Fly
AxoGen reports inducement grant under Nasdaq listing rule
5M ago
AxoGen Updates Corporate Presentation for Stakeholders
PremiumCompany AnnouncementsAxoGen Updates Corporate Presentation for Stakeholders
6M ago
AxoGen sees FY24 revenue $182M-$186M, consensus $178.9M
Premium
The Fly
AxoGen sees FY24 revenue $182M-$186M, consensus $178.9M
6M ago
AxoGen reports Q2 adjusted EPS 5c, consensus (4c)
Premium
The Fly
AxoGen reports Q2 adjusted EPS 5c, consensus (4c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100